ZBIO
Zenas BioPharma, Inc.
NASDAQ · Healthcare
| Dec 2025 | Dec 2024 | Dec 2023 | |
|---|---|---|---|
| Operating | |||
| Operating Cash Flow | — | — | — |
| Net Income | — | — | — |
| Depreciation & Amort. | — | — | — |
| Stock-Based Comp. | — | — | — |
| Changes in WC | — | — | — |
| Investing | |||
| Capital Expenditures | 18,000 | 131,000 | 17,000 |
| Acquisitions | — | — | — |
| Investing Cash Flow | — | — | — |
| Financing | |||
| Debt Repayment | — | — | — |
| Common Stock Issued | — | — | — |
| Buybacks | — | — | — |
| Dividends Paid | — | — | — |
| Financing Cash Flow | — | — | — |
| Summary | |||
| Free Cash Flow | -172.4M | -119.8M | -30.5M |
| Net Change in Cash | — | — | — |